What mifepristone fight’s really about: Why Maryland must protect providers, patients

The court fight over mifepristone was never about the drug's safety, but about spreading confusion and hindering medication abortions, write Amy Hagstrom Miller and Christie Pitney, which is why Maryland needs to step up and protect patients and providers.

By: Amy Hagstrom Miller, Christie Pitney

Outlets: Maryland Matters

Published: June 8, 2026

Words: 867

Last Updated: 1 month, 3 weeks ago

Body Text Preview

On May 1, the ultraconservative 5th U.S. Circuit Court of Appeals did something equal parts unprecedented and outrageous: It overruled the scientific and medical expertise of the Food and Drug Administration, reinstating a nationwide ban on mailing mifepristone, a safe, effective medication used in most U.S. abortions and early miscarriage care. The ruling also banned filling a prescription for mifepristone at a retail pharmacy.

While the U.S. Supreme Court blocked this decision from taking effect …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

About

FAQ

Email Us